Patients and pregnant women, people out to buy essential items, and those travelling to or from railway stations, bus stops and airports will be exempted from the night curfew that kicks in at 11 pm on Monday due to rising COVID-19 cases in Delhi, according to a DDMA order.
COVAX, 'the global COVID vaccine equity scheme', has so far delivered 65 million doses to 124 countries and economies but it is dependent on countries and manufacturers honouring their commitments.
'For the next two years, we expect the bulk of earnings growth contribution from sectors like financials and energy, where the outlook remains positive, while the sectors which are linked to domestic consumption and are currently witnessing strains on margins have low salience for Nifty earnings.'
India procured around 5 lakh rapid antibody test kits from the two Chinese firms, Guongzhou Wondfo Biotech and Livzon Diagnostics, and they were distributed to several states reporting rising cases of the coronavirus infection.
Covaxin was found to have 78 per cent efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements, said the global health body.
Mumbai, with an estimated population of nearly 20 million, has been testing 1,200-1,400 people per day. Delay in the delivery of rapid antibody test kits has forced the BMC to restrict its testing net.
The first fatality from COVID-19 was reported from the Washington state on February 26.
During this period, all government and private offices, shopping complexes, malls, bars, sports complexes, pubs and beauty parlours will remain closed.
'However, the importance of children in transmitting the virus remains uncertain,' the scientists cautioned in the study. 'Coronaviruses are a large family of viruses that can cause infection and disease in animals, capable of rapid mutation and recombination, leading to novel viruses that can spread from animals to humans,' they said.
The B-1617 variant of the coronavirus, first identified in India, has been classified as a variant of concern at the global level by the World Health Organisation (WHO).
The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.
'The lockdown was for both: To flatten the curve or more correctly, delay the rapid spread of COVID outbreak, and to create healthcare infrastructure.'
Six Covid-19 cases were reported on Wednesday after screening 3,476 passengers of 11 flights that arrived in India from "at-risk" countries and the samples have been sent for genomic sequencing, the Health Ministry said amid concerns over the 'Omicron' variant of coronavirus.
We'll need to wait a couple of years to see how many restructured loans turn bad and whether some banks fall victim to their obsession for growth, explains Tamal Bandyopadhyay.
Insurance companies are seeking a separate deduction limit of Rs 1 lakh for insurance premium payment under Section 80C of the Income Tax Act in the upcoming Union Budget to bring in more people under the ambit of insurance. The insurers also want reduction in the goods and services tax (GST) rate of 18 per cent currently applied on health insurance products to 5 per cent to make such products more affordable to common people. Finance Minister Nirmala Sitharaman will present the Union Budget for 2022-23 on February 1.
About 18-19 coronavirus vaccine candidates are in different clinical trial stages and may be available in the coming months, Health Minister Harsh Vardhan said on Monday.
Tata Motors on Tuesday launched its second electric vehicle -- Tigor EV, catering to the personal segment in the domestic market, priced between Rs 11.99 lakh and Rs 13.14 lakh (ex-showroom). The model comes in three variants, priced at Rs 11.99 lakh, Rs 12.49 lakh and Rs 12.99 lakh. A dual tone top-end trim is tagged at Rs 13.14 lakh. The auto major has already achieved success with its first electric model, Nexon EV and now commences deliveries of Tigor EV from around 150 sales outlets in 70 cities across the country.
France on Sunday delivered to India 28 tonnes of ready-to-use medical supplies including eight large oxygen plants while the US sent to India a third flight that brought over 1000 oxygen cylinders
The study will provide information about the spread of the infection and also throw light on herd immunity.
Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. He said last week India was ready to do everything possible for a healthy planet.
Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster
Since returning home, his physical exam has remained stable and devoid of any indications to suggest progression of illness, his doctor said.
A total of 25,12,388 samples have been tested for coronavirus infection as on 9 am, May 20 all over the country.
In another milestone for the DMRC, driverless train operations on 59-km Pink Line of the Delhi Metro were flagged off on Thursday.
The average Tests Per Million Per Day have increased from 237 in the second week of July to 758 in the first week of September.
The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing 1,11,000 vials of the drug per month from July.
The COVID-19 pandemic has not only affected outpatient services, but also led to deferment of elective surgeries, and resulted in the loss of medical tourism, all of which would hit the FY21 financials.
As the farmers prepare to leave their protest sites on Delhi's borders on Saturday after the government repealed the farm laws and acceded to their other demands, many say they will reinstall their tents in their villages as a symbol of their long, arduous struggle.
Fortis Healthcare Chairman Malvinder Mohan Singh on Wednesday said it planned to launch an IPO for its diagnostics business unit, Super Religare Laboratories (SRL), in 2011. SRL had acquired the diagnostics business of Piramal Healthcare for Rs 600 crore in the first quarter of this financial year.
As has been reported from states and UTs that have pushed ahead with aggressive testing, there is a commensurate decline in the positivity rate, the health ministry said.
Deaths are significantly less in the third wave of the Covid-19 pandemic in comparison to the second wave, and the current surge is not witnessing increase in severe illness or death following high vaccination uptake, the government said on Thursday.
The survey was carried out in wards R-north (Borivali), M-West (Mankhurd and Govandi) and F-North (Worli and Lower Parel) in the second half of August.
Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine. Sohini Das profiles its 39-year-old CEO.
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.
The new portal provides physicians with a single, easy-to-use interface that speeds up the order-to-delivery of devices, processing of diagnostic data and management of insurance claims.
The offering comprises secondary sale of 13.68 million shares, constituting 27.3 per cent stake.
New age diagnostic tools come in handy for BharatBenz to predict repair needs and breakdown in advance.
If a retail investor wants exposure to a healthcare ETF, it should be a part of his satellite portfolio, suggests Sanjay Kumar Singh.
PM Modi said that it was an honour to be a trusted partner during the pandemic adding that the two countries will continue to strengthen cooperation on healthcare.
"The recovery rate is 58.56 per cent amongst COVID-19 patients," the ministry said.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances